Generation and selection of immunized Fab phage display library against human B cell lymphoma

Cell Research

Volumn 17, Issue 7, 2007, Pages 650-660

  Shen, Yongmei ^a   Yang, Xiaochun ^a   Dong, Ningzheng ^b   Xie, Xiaofang ^a   Bai, Xia ^b   Shi, Yizhen ^a  

^a THE SECOND AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

B cell lymphoma; Fab; pComb3H SS vector; Phage display library

Indexed keywords

ANTISERUM; IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOGLOBULIN KAPPA CHAIN; PEPTIDE LIBRARY;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; B CELL LYMPHOMA; BAGG ALBINO MOUSE; BIOLOGICAL MODEL; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE VECTOR; GENETICS; HUMAN; IMMUNIZATION; IMMUNOLOGY; MOLECULAR GENETICS; MOUSE; PATHOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY; TUMOR CELL LINE; WESTERN BLOTTING;

AMINO ACID SEQUENCE; ANIMALS; BLOTTING, WESTERN; CELL LINE, TUMOR; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENETIC VECTORS; HUMANS; IMMUNE SERA; IMMUNIZATION; IMMUNOGLOBULIN FAB FRAGMENTS; IMMUNOGLOBULIN KAPPA-CHAINS; LYMPHOMA, B-CELL; MICE; MICE, INBRED BALB C; MODELS, GENETIC; MOLECULAR SEQUENCE DATA; PEPTIDE LIBRARY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY, AMINO ACID;

MURINAE; MUS;

EID: 34547216416     PISSN: 10010602     EISSN: 17487838     Source Type: Journal    
DOI: 10.1038/cr.2007.57     Document Type: Article

References (35)

1. Kohler G, Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 1975; 256:495- 497.
2. Schroff RW, Foon KA, Beatty SM, Oldham RK, Morgan AC Jr. Human anti-murine immunoglobulin responses in patients receiving monoclonal antibody therapy. Cancer Res 1985; 45:879-885.
3. Shawler DL, Bartholomew RM, Smith LM, Dillman RO. Human immune response to multiple injections of murine monoclonal IgG. J Immunol 1985; 135:1530-1535.
4. Reff ME, Hariharan K, Braslawsky G. Future of monoclonal antibodies in the treatment of hematologic malignancies. Cancer Control 2002; 9:152-166.
5. Jones ML, Barnard RT. Chimerization of multiple antibody classes using splice overlap extension PCR. Biotechniques 2005; 38:181-182.
6. Dall'Acqua WF, Damschroder MM, Zhang J, et al. Antibody humanization by framework shuffling. Methods 2005; 36:43-60.
7. Popkov M, Rader C, Barbas III CF. Isolation of human prostate caner cell reactive antibodies using phage display technology. J Immunol methods 2004; 291:137-151.
8. Maloney DG. Immunotherapy for non-Hodgkin's lymphoma: monoclonal antibodies and vaccines. J Clin Oncol 2005; 23:6421-6428.
9. Tobinai K. Antibody therapy for malignant lymphoma. Intern Med 2007; 46:99-100.
10. Marcus R, Hagenbeek A. The therapeutic use of rituximab in non-Hodgkin's lymphoma. Eur J Haematol Suppl 2007; 67:5-14.
11. Batra SK, Jain M, Wittel UA, Chauhan SC, Colcher D. Pharmaco-kinetics and biodistribution of genetically engineered antibodies. Curr Opin Biotechnol 2002; 13:603-608.
12. Krauss J. Recombinant antibodies for the diagnosis and treatment of cancer. Mol Biotechnol 2003; 25:1-17.
13. Itoh K. Development of diagnostically and therapeutically useful human antibody medicines by phage display system. Yakugaku Zasshi 2007; 127:43-53.
14. Larralde OG, Martinez R, Camacho F, et al. Identification of hepatitis A virus mimotopes by phage display, antigenicity and immunogenicity. J Virol Methods 2007; 140:49-58.
15. De Pascalis R, Gonzales NR, Padlan EA, et al. In vitro affinity maturation of a specificity-determining region-grafted humanized anticarcinoma antibody: isolation and characterization of minimally immunogenic high-affinity variants. Clinical Cancer Research 2003; 9:5521-5531.
16. Wei Chan S, Ong GI and Nathan S. Neutralizing chimeric mouse-human antibodies against Burkholderia pseudomallei protease: xpression, purification and characterization. Biochem Mol Biol 2004; 37:556-564.
17. rd. Methods for the generation of chicken monoclonal antibody fragments by phage display. J Immunol Methods 2000; 242:159-181.
18. Orum H, Andersen PS, Oster A, et al. Efficient method for constructing comprehensive murine Fab antibody libraries displayed on phage. Nucleic Acids Res 1993; 21:4491-4498.
19. rd, Burton DR, Ditzel HJ. Human monoclonal Fab fragments specific for viral antigens from combinatorial IgA libraries. Immunotechnology 1995; 1:21-28.
20. Li J, Pereira S, Van Belle P, et al. Isolation of the melanoma-associated antigen p23 using antibody phage display. J Immunol 2001; 166:432-438.
21. Dantas-Barbosa C, Brigido MM, Maranhao AQ. Construction of a human Fab phage display library from antibody repertoires of osteosarcoma patients. Genet Mol Res 2005; 4:126-140.
22. Bruenke J, Fischer B, Barbin K, et al. A recombinant bispecific single-chain Fv antibody against HLA class II and FcgrmmaRIII (CD16) triggers effective lysis of lymphoma cells. Br J Haematol 2004; 125:167-179.
23. Dong L, Masaki Y, Takegami T, et al. Cloning and expression of two human recombinant monoclonal Fab fragments specific to EBV capsid antigen. Int Immunol 2007; 19:331-336.
24. Wu BP, Xiao B, Wan TM, Zhang YL, Zhang ZS, Zhou DY. Construction and selection of the natural immune Fab antibody phage display library from patients with colorectal cancer. World J Gastroenterol 2001; 7:811-815.
25. Nathan S, Rader C, Barbas CF. Neutralization of Burkholderia pseudomallei protease by Fabs generated through phage display. iosci Biotechnol Biochem 2005; 69:2302-2311.
26. Smith JW, Ruoslahti E. Harvesting molecular diversity-biology's new commodity. Biotechnol Genet Eng Rev 1997; 14:51-65.
27. Watters JM, Telleman P, Junghans RP. An optimized method for cell-based phage display panning. Immunotechnology 1997;3: 21-29.
28. Pereira S, Maruyama H, Siegel D, et al. A model system for detection and isolation of a tumor cell surface antigen using antibody phage display. J Immunol Methods 1997; 203:11-24.
29. Manser T, Tumas-Brundage KM, Casson LP, et al. The roles of antibody variable region hypermutation and selection in the development of the memory B-cell compartment. Immunol Rev 1998;162:183-196.
30. Rader C. Antibody libraries in drug and target discovery. Drug Discov Today 2001; 6:36-43.
31. Hoogenboom HR, Chames P. Natural and designer binding sites made by phage display technology. Immunol Today 2000; 21:371-378.
32. Desogus A, Burioni R, Ingianni A, Bugli F, Pompei R, Fadda G. Production and characterization of a human recombinant monoclonal Fab fragment specific for influenza A viruses. Clin Diagn Lab Immunol 2003; 10:680-685.
33. Kupsch JM, Tidman NH, Kang NV, et al. Isolation of human tumor-specific antibodies by selection of an antibody phage library on melanoma cells. Clin Caner Res 1999; 5:925-931.
34. Mutuberria R, Stijn S, Huijbers A, et al. Isolation of human antibodies to tumor-associated endothelial cell markers by in vitro human endothelial cell selection with phage display libraries. J Immunol Methods 2004; 287:31-47.
35. Press OW, Farr AG, Borroz KI, Anderson SK, Martin PJ. Endocytosis and degradation of monoclonal antibodies targeting human B-cell malignancies. Cancer Res 1989; 49:4906-4912.